Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
NCT01544608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1076
Last updated 2013-06-20
Summary
The primary objective of this Non- Interventional Study (NIS) is to describe the use of atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to acute psychotic episode by evaluation of drug, dose and mode of administration of the medication.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Talaat Matar, CONSULTANT PSYCHIATRIST · Obaid Alla Hospital,Ras Al Khaima,UAE
-
Tarek Darwish, CONSULTANT PSYCHIATRIST · Sheikh Khalifa Medical City(SKMC), Abudhabi,UAE
-
Sohail Khan, CONSULTANT PSYCHIATRIST · Jeddah Psychiatric hospital,Jeddah, Saudi Arabia
-
Tarek Okasha, PROFESSOR · Ain Shams University, Cairo, Egypt
-
Mohamed Nasr, PROFESSOR · Cairo University, Egypt
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- Egypt
- Saudi Arabia
- United Arab Emirates
Study Locations
More Related Trials
-
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)
NCT01192867 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)
NCT04010864 ·Status: UNKNOWN
-
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
NCT02469155 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia
NCT03130465 ·Status: UNKNOWN
-
A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.
NCT01955564 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
NCT01527305 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
NCT01051531 ·Status: COMPLETED ·Phase: PHASE3
-
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT00731549 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
NCT02935998 ·Status: UNKNOWN ·Phase: PHASE4
-
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
NCT01150448 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
NCT00061802 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
NCT00634348 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia
NCT00460512 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
NCT01149655 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
NCT02137993 ·Status: COMPLETED ·Phase: PHASE4
-
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
NCT00159770 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia
NCT01615185 ·Status: TERMINATED ·Phase: PHASE4
-
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
NCT02192723 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers
NCT01511510 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Seroquel in First Episode Schizophrenia
NCT00254241 ·Status: COMPLETED ·Phase: PHASE4
-
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
NCT04446234 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
NCT01685931 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
NCT01942382 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
NCT00723606 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT01509053 ·Status: TERMINATED ·Phase: PHASE3